Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-07

Clinical Trial Update: Memantine for Spasticity in MS Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating memantine for spasticity in people with multiple sclerosis has completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: University of Rochester | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2015-12-07